TrialPloS one2009

The synthetic Plasmodium falciparum circumsporozoite peptide PfCS102 as a malaria vaccine candidate: a randomized controlled phase I trial.

Régine Audran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.